Passa al contenuto
Merck

Documenti fondamentali

Visualizza tutta la documentazione

Vai a

F8065

Fucoidan from Macrocystis pyrifera

≥85%

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Taglio della confezioneSKUDisponibilitàPrezzo
500 mg
Per informazioni sulla disponibilità, contatta il Servizio Clienti.
156,00 €

Informazioni su questo articolo

Numero CAS:
9072-19-9
MDL number:
MFCD02752814
NACRES:
NA.25
UNSPSC Code:
12352201

156,00 €

Per informazioni sulla disponibilità, contatta il Servizio Clienti.
​
Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti

biological source

algae (Macrocystis pyrifera)

Quality Level

200

assay

≥85%

form

powder

color

white to brown

working range

4-7

solubility

water: 10 mg/mL, clear to hazy, colorless to very faintly brown

storage temp.

room temp

General description

Fucoidan is a fucose-rich, sulfated polysaccharide isolated from several species of brown seaweed.

Biochem/physiol Actions

Studies of fucoidan have found it to have a broad variety of biological activities including antitumor and antiangogenic activities, immunomodulatory, anti-inflammatory, anticoagulant, antithrombotic, and antioxidant activities. Fucoidan induces macrophage activation which subsequently activates mitogen activated protein kinases (MAPKs) and results in natural killer cell proliferation. Fucoidan acts as a nonselective selectin blocker and has been shown to induce apoptosis and suppress angiogenesis.

Other Notes

To gain a comprehensive understanding of our extensive range of Polysaccharides for your research, we encourage you to visit our Carbohydrates Category page.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
F8190F8315F5631
Fucoidan from Macrocystis pyrifera ≥85%

Sigma-Aldrich

F8065

Fucoidan from Macrocystis pyrifera

Fucoidan from Fucus vesiculosus ≥95%

Sigma-Aldrich

F8190

Fucoidan from Fucus vesiculosus

Fucoidan from Undaria pinnatifida ≥95%

Sigma-Aldrich

F8315

Fucoidan from Undaria pinnatifida

Fucoidan from Fucus vesiculosus Crude

Sigma-Aldrich

F5631

Fucoidan from Fucus vesiculosus

biological source

algae (Macrocystis pyrifera)

biological source

algae (Fucus Vesiculosus)

biological source

algae (Undaria pinnatifida)

biological source

algae (Fucus Vesiculosus)

assay

≥85%

assay

≥95%

assay

≥95%

assay

-

solubility

water: 10 mg/mL, clear to hazy, colorless to very faintly brown

solubility

water: 10 mg/mL, clear, colorless to faintly yellow

solubility

water: 10 mg/mL, clear to slightly hazy, colorless to faintly yellow

solubility

H2O: 10 mg/mL, clear to hazy, faintly yellow to brownish-yellow

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

powder

form

powder

form

powder

form

powder

storage temp.

room temp

storage temp.

room temp

storage temp.

room temp

storage temp.

room temp

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
0000560275
0000560275
0000553485
0000542624
0000553485

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Articoli

Carbohydrates as Versatile Enablers of Advanced Drug Delivery Systems

Explore how carbohydrates function as excipients and carriers in drug delivery, with insights into mechanisms, case studies, and future trends.

Pharmaceutical Research Applications of Carbohydrates and Polysaccharides

Discover the role of carbohydrates in drug delivery, from solubility and stability improvement to advanced controlled-release systems.

Xiang Li et al.
Arteriosclerosis, thrombosis, and vascular biology, 34(8), 1661-1667 (2014-06-07)
Nuclear imaging of active plaques still remains challenging. Advanced atherosclerotic plaques have a strong expression of P-selectin by the endothelium overlying active atherosclerotic plaques, but not on the endothelium overlying inactive fibrous plaques. We proposed a new approach for noninvasive
Anna Pielesz et al.
The Analyst, 140(13), 4599-4607 (2015-06-02)
Differential scanning calorimetry (DSC) and thermogravimetric (TGA) investigations, acetate electrophoresis (CAE), Fourier-transform infrared spectrometry (FTIR), scanning electron microscopy (SEM) analysis and microbiological procedures were all carried out after heating the samples to a temperature sufficient for simulating a burn incident.
Wentong Cui et al.
Laboratory investigation; a journal of technical methods and pathology, 94(4), 382-393 (2014-03-13)
Endothelial dysfunction, characterized by impairment of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) bioavailability, has been implicated in diabetic cardiovascular pathogenesis. In this study, low-molecular-weight fucoidan (LMWF), which has multiple biological activities including anti-inflammatory and anti-oxidative properties, was
Visualizza tutti i documenti correlati

Numero articolo commerciale globale

SKUGTIN
F8065-500MG04061833620007

Domande

Recensioni

Nessuna valutazione

Filtri attivi